The State of AI Regulation in Healthcare: Still Complicated
This health law analysis reviews the current landscape of U.S. healthcare AI regulation, focusing on how the FDA distinguishes higher‑risk clinical AI tools from lower‑risk workflow applications. It explains that the FDA’s January 2026 clinical decision support software guidance clarifies when AI tools that influence clinical judgment or patient management are likely to require formal review or clearance.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.